why choose us

First received: September 18, 2023

Clinical Trial: A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Non-alcoholic Steatohepatitis

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of Efinopegdutide (MK-6024) in Participants With Moderate and Severe Hepatic Impairment

Brief Summary: The purpose of this study is to evaluate the pharmacokinetics of efinopegdutide in participants with hepatic impairment compared to healthy participants, and to examine the safety and tolerability of efinopegdutide.

Read more